Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hansel Pharmaceuticals is a Pakistan-based pharmaceutical company that focuses on the development, manufacturing, and marketing of high-quality generic medicines. As a member of the Sitara Group of Industries, the company leverages significant industrial expertise to maintain a state-of-the-art manufacturing facility in Lahore. Its product portfolio spans several therapeutic areas, including gastroenterology, respiratory, orthopedics, and pediatrics, with a strong emphasis on gastrointestinal health. Key commercial products include Hansel-D (dexlansoprazole) and Hansel-M (montelukast), which serve large patient populations in the region. The company is committed to international quality standards and aims to provide affordable healthcare solutions through its extensive domestic distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hansel Pharmaceuticals.